Cardiopulmonary Resuscitation Outcomes in Patients with Pulmonary Arterial Hypertension (PAH)

被引：0
|
作者：
Mathers, H. [1 ]
Pebley, N. B. [1 ]
Odish, M. F. [2 ]
Papamatheakis, D. G. [2 ]
Poch, D. S. [2 ]
Kim, N. H. [2 ]
Fernandes, T. M. [2 ]
Wardi, G. [2 ]
Sell, R. E. [2 ]
机构：
[1] Univ Calif San Diego UC San Diego, Sch Med, La Jolla, CA USA
[2] Univ Calif San Diego UC San Diego, Div Pulm Crit Care & Sleep Med, La Jolla, CA USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2020年 / 201卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A2922
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Pulmonary Function and response to treatment in pulmonary arterial hypertension (PAH)
    Barbera, Joan Albert
    Galie, Nazzareno
    Frost, Adaani
    Ghofrani, Hossein Ardeschir
    Hoeper, Marius
    Mclaughlin, Vallerie
    Peacock, Andrew
    Simonneau, Gerald
    Vachiery, Jean-Luc
    Blair, Christiana
    Miller, Karen
    Harris, Julia
    Langley, Jonathan
    Rubin, Lewis
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [42] Regional Pulmonary Vascular Resistance in Pulmonary Arterial Hypertension (PAH)
    Winkler, T.
    Kohli, P.
    Kelly, V. J.
    Kehl, E. G.
    Kone, M. T.
    Hibbert, K.
    Rodriguez-Lopez, J. M.
    Systrom, D. M.
    Waxman, A. B.
    Venegas, J. G.
    Channick, R. N.
    Harris, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [43] TREATMENT AND OUTCOMES IN PATIENTS HOSPITALIZED FOR SEPSIS WITH PULMONARY ARTERIAL HYPERTENSION COMPARED TO PATIENTS WITHOUT PULMONARY ARTERIAL HYPERTENSION
    Chen, Haidee
    Flynn, Spencer
    Kerbel, Russell
    Gupta, Summer
    Jasuja, Sonia
    Saggar, Rajan
    Channick, Richard N.
    Sherman, Alexander
    CHEST, 2023, 164 (04) : 5963A - 5964A
  • [44] Pulmonary Capillary Wedge Pressure (pcwp) And Its Role In Determining Outcomes In Pulmonary Arterial Hypertension (pah)
    Venepally, S.
    Ronaghi, R.
    Khan, A.
    Balasubramanian, V.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [45] One year experience with intravenous treprostinil in pulmonary arterial hypertension (PAH) patients
    McLaughlin, VV
    Barst, R
    Gomberg-Maitland, M
    Tapson, V
    Krichman, A
    Widlitz, A
    Rich, S
    Benza, R
    CHEST, 2005, 128 (04) : 160S - 160S
  • [46] CLINICOPATHOLOGICAL CORRELATES IN 24 PATIENTS WITH ARDS AND PULMONARY ARTERIAL-HYPERTENSION (PAH)
    DIVERTIE, GD
    EDWARDS, WD
    DIVERTIE, MB
    OFFORD, KP
    MARSH, HM
    CHEST, 1986, 89 (06) : S454 - S454
  • [47] Cicletanine Therapy Is Well Tolerated in Patients with Advanced Pulmonary Arterial Hypertension (PAH)
    Waxman, A. B.
    Lawler, L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [48] Sitaxsentan improves time to clinical worsening in patients with pulmonary arterial hypertension (PAH).
    Badesch, D
    Galie, N
    Langleben, D
    Naeije, R
    Simonneau, G
    Barst, RJ
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S167 - S167
  • [49] Macitentan for pulmonary arterial hypertension (PAH): Early clinical experience of 94 patients
    Hamilton, Neil
    Sellars, Michaela
    Graves, Mark
    Armstrong, Iain
    Charalampopolous, Athanasios
    Kiely, David
    Elliot, Charlie
    Condliffe, Robin
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [50] Sitaxsentan (STX) improves ventricular synchrony in patients with pulmonary arterial hypertension (PAH)
    Pulido, T.
    Namendys-Silva, S. A.
    Vallejo, E.
    Jimenez, L.
    Moreno-Sanchez, P.
    Rueda, T.
    Bautista, E.
    Sandoval, J.
    EUROPEAN HEART JOURNAL, 2006, 27 : 625 - 625
12345